Bluejay Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Bluejay Therapeutics's estimated annual revenue is currently $3.9M per year.
- Bluejay Therapeutics's estimated revenue per employee is $94,512
- Bluejay Therapeutics's total funding is $243M.
Employee Data
- Bluejay Therapeutics has 41 Employees.
- Bluejay Therapeutics grew their employee count by 95% last year.
Bluejay Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder, CEO and Chairman | Reveal Email/Phone |
2 | Chief Scientific Officer | Reveal Email/Phone |
3 | Chief Medical Officer | Reveal Email/Phone |
4 | Chief Commercial Officer | Reveal Email/Phone |
5 | Chief Medical Officer | Reveal Email/Phone |
6 | Chief Commercial Officer | Reveal Email/Phone |
7 | Chief Financial Officer | Reveal Email/Phone |
8 | SVP, Head Finance | Reveal Email/Phone |
9 | Head Immunology | Reveal Email/Phone |
10 | VP, Biochemistry | Reveal Email/Phone |
Bluejay Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Bluejay Therapeutics?
The mission of Bluejay Therapeutics is to develop innovative cures for infectious diseases with the first target indication of chronic HBV infection. Bluejay has exclusively licensed global rights to advance several HBV programs, including a best-in-class anti-HBsAg monoclonal antibody.
keywords:N/A$243M
Total Funding
41
Number of Employees
$3.9M
Revenue (est)
95%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.4M | 41 | -16% | $100.3M |
#2 | $8.9M | 41 | -5% | N/A |
#3 | $4.6M | 41 | N/A | N/A |
#4 | $4.4M | 41 | -31% | $2.8M |
#5 | $4.5M | 41 | 71% | $45.1M |